Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at PLN 36.7B, ahead of BioNTech (PLN 34.2B) and Gilead Sciences (PLN 30.4B). Figures as of 19 Nov 2026, 00:22 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenPLN 36.7B
Median
PLN 1.7B
Combined market value
PLN 3.36T
Countries
5

Market values as of .

All countries
All sectors
Biotech
PLN
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CarePLN 36.7BPLN 965.4BPLN 1,784.84 3.07% down 34% up United States
2BioNTechBNTX · Health CarePLN 34.2BPLN 83BPLN 334.78 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CarePLN 30.4BPLN 842.8BPLN 679.45 0.75% down 33% up United States
4argenxARGX · Health CarePLN 14BPLN 238BPLN 3,784.67 0.66% down 4% up Belgium
5BiogenBIIB · Health CarePLN 12.1BPLN 149.4BPLN 1,010.89 0.25% up 49% up United States
6ModernaMRNA · Health CarePLN 10.4BPLN 320.2BPLN 791.27 4.84% down 755% up United States
7ImmunovantIMVT · Health CarePLN 3.6BPLN 27.6BPLN 133.37 0.12% down 43% up United States
8QiagenQGEN · Health CarePLN 3.4BPLN 41.1BPLN 199.28 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CarePLN 2.9BPLN 66.3BPLN 654.84 1.84% down 20% up United States
10RepligenRGEN · Health CarePLN 2.3BPLN 44.4BPLN 694.29 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CarePLN 2BPLN 37.6BPLN 1,267.95 5.62% up 46% up United States
12ExelixisEXEL · Health CarePLN 1.9BPLN 67BPLN 274.59 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CarePLN 1.5BPLN 139BPLN 642.62 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CarePLN 1.4BPLN 41.6BPLN 487.05 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CarePLN 1.4BPLN 15.7BPLN 161.60 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CarePLN 1.3BPLN 23.5BPLN 193.00 6.48% up 14% up United States
17Bio-TechneTECH · Health CarePLN 1.1BPLN 46BPLN 292.52 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CarePLN 843.8MPLN 25.7BPLN 393.28 1.04% up 396% up United States
19Twist BioscienceTWST · Health CarePLN 736MPLN 31.9BPLN 467.83 3.88% up 340% up United States
20VaxcytePCVX · Health CarePLN 699.5MPLN 37.2BPLN 235.30 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CarePLN 538.1MPLN 43.9BPLN 385.20 0.18% down 37% up United States
22ImmunityBioIBRX · Health CarePLN 355.2MPLN 28.7BPLN 26.94 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CarePLN 283.5MPLN 18.5BPLN 114.43 0.11% down 88% up United States
24CG OncologyCGON · Health CarePLN 130.6MPLN 28.7BPLN 321.67 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0209 PLN).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (PLN 36.7B), BioNTech (PLN 34.2B) and Gilead Sciences (PLN 30.4B) are the top three of the 24 biotech companies ranked by cash on hand as of 19 Nov 2026, 00:22 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of PLN 3.36T as of 19 Nov 2026, 00:22 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.